Q4 2023 · 13F-HR
Nan Fung Group Holdings Ltdholdings as filed
Filed 2024-02-13 · accession 0001012975-24-000077
$160.6M
Reported value
39
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 48576A100 | — | KARUNA THERAPEUTICS INC | $71.4M | 44.5% | 225,688 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $16.6M | 10.3% | 119,196 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $11.9M | 7.42% | 368,665 | Common | SOLE |
| H5870P102 | OCS | OCULIS HOLDING AG | $5.8M | 3.63% | 518,933 | Common | SOLE |
| 30223G102 | EXAIEUR | EXSCIENTIA PLC | $5.5M | 3.43% | 859,892 | Common | SOLE |
| 02083G100 | NVLSEUR | ALPINE IMMUNE SCIENCES INC | $5.0M | 3.13% | 263,940 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $4.9M | 3.06% | 106,680 | Common | SOLE |
| 83444K105 | SLGCUSD | SOMALOGIC INC | $4.3M | 2.67% | 1,696,558 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $3.8M | 2.35% | 137,038 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $3.7M | 2.32% | 304,277 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $2.8M | 1.77% | 96,100 | Common | SOLE |
| 69404D108 | PACB | PACIFIC BIOSCIENCES CALIF IN | $2.7M | 1.68% | 274,488 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $2.2M | 1.35% | 12,022 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $2.0M | 1.25% | 32,022 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $1.9M | 1.20% | 913,550 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $1.8M | 1.15% | 40,070 | Common | SOLE |
| 753018100 | RANI | RANI THERAPEUTICS HLDGS INC | $1.6M | 1.02% | 493,584 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $1.6M | 0.97% | 184,739 | Common | SOLE |
| 30161Q104 | EXEL | EXELIXIS INC | $1.5M | 0.96% | 64,200 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $1.3M | 0.81% | 1,166,952 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $1.1M | 0.68% | 47,936 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $1.1M | 0.67% | 47,150 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $938,799 | 0.58% | 29,984 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $740,647 | 0.46% | 49,082 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $624,636 | 0.39% | 41,950 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $580,800 | 0.36% | 40,000 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $544,015 | 0.34% | 1,430 | Common | SOLE |
| 04746L104 | — | ATHIRA PHARMA INC | $437,400 | 0.27% | 180,000 | Common | SOLE |
| 270087208 | — | EARGO INC | $383,071 | 0.24% | 147,904 | Common | SOLE |
| 23306J101 | — | DBV TECHNOLOGIES S A | $353,441 | 0.22% | 370,950 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $348,558 | 0.22% | 3,615 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $273,491 | 0.17% | 1,182 | Common | SOLE |
| N01045108 | — | AFFIMED N V | $232,795 | 0.14% | 372,472 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $106,904 | 0.07% | 17,847 | Common | SOLE |
| 36338D108 | GRTX | GALERA THERAPEUTICS INC | $89,163 | 0.06% | 613,223 | Common | SOLE |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $71,495 | 0.04% | 12,521 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $59,651 | 0.04% | 19,622 | Common | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $55,045 | 0.03% | 62,106 | Common | SOLE |
| 157085101 | CERS | CERUS CORP | $30,612 | 0.02% | 14,172 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.